Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Taylor

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2021
The genetic architecture of Plakophilin 2 cardiomyopathyAnnika M Dries, Anna Kirillova, Chloe M Reuter, et al.
European Heart Journal|August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failureDouglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Circulation. Genomic and Precision Medicine|August 18, 2023
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of <i>RBM20</i> VariantsDouglas E Cannie, Alexandros Protonotarios, Athanasios Bakalakos, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
Cardiovascular Research|January 11, 2017
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesisAnneline S J M Te Riele, Esperanza Agullo-Pascual, Cynthia A James, et al.
Cancer Research|February 2, 2021
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic CancerAdam C Mueller, Miles Piper, Andrew Goodspeed, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2021
The genetic architecture of Plakophilin 2 cardiomyopathyAnnika M Dries, Anna Kirillova, Chloe M Reuter, et al.
European Heart Journal|August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failureDouglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Circulation. Genomic and Precision Medicine|August 18, 2023
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of <i>RBM20</i> VariantsDouglas E Cannie, Alexandros Protonotarios, Athanasios Bakalakos, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
Cardiovascular Research|January 11, 2017
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesisAnneline S J M Te Riele, Esperanza Agullo-Pascual, Cynthia A James, et al.
Cancer Research|February 2, 2021
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic CancerAdam C Mueller, Miles Piper, Andrew Goodspeed, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Pageof 26